[{"_id":"551f89b631cae9239deb1ee0","会社名":"科研製薬(株)【4521】","証券コード":"4521","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月12日","決算月数":"12か月","売上高":"88,946百万円","営業利益":"15,872百万円","経常利益":"15,521百万円","当期利益":"9,735百万円","EPS（一株当たり利益）":"114.14円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"805.89円","総資産":"106,465百万円","自己資本":"68,096百万円","資本金":"23,853百万円","有利子負債":"4,195百万円","自己資本比率":"64.0%","ROA（総資産利益率）":"9.04%","ROE（自己資本利益率）":"14.46%","総資産経常利益率":"14.41%","__v":0,"日付":"2015-04-04T06:50:30.507Z"},{"_id":"551f89b631cae9239deb1ee1","会社名":"科研製薬(株)【4521】","証券コード":"4521","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月13日","決算月数":"12か月","売上高":"87,054百万円","営業利益":"14,611百万円","経常利益":"14,250百万円","当期利益":"8,991百万円","EPS（一株当たり利益）":"103.30円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"771.10円","総資産":"108,911百万円","自己資本":"66,578百万円","資本金":"23,853百万円","有利子負債":"8,390百万円","自己資本比率":"61.1%","ROA（総資産利益率）":"8.40%","ROE（自己資本利益率）":"13.98%","総資産経常利益率":"13.32%","__v":0,"日付":"2015-04-04T06:50:30.507Z"},{"_id":"551f89b631cae9239deb1ee2","会社名":"科研製薬(株)【4521】","証券コード":"4521","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月14日","決算月数":"12か月","売上高":"87,997百万円","営業利益":"15,180百万円","経常利益":"14,803百万円","当期利益":"8,282百万円","EPS（一株当たり利益）":"92.46円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"702.31円","総資産":"105,108百万円","自己資本":"62,071百万円","資本金":"23,853百万円","有利子負債":"8,390百万円","自己資本比率":"59.1%","ROA（総資産利益率）":"8.14%","ROE（自己資本利益率）":"13.53%","総資産経常利益率":"14.54%","__v":0,"日付":"2015-04-04T06:50:30.507Z"}]